Randomized clinical trials: Slow death by a thousand unnecessary policies?

被引：33

作者：

Yusuf, S ^{[1
]}

机构：

[1] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada

来源：

关键词：

D O I：

10.1503/cmaj.1040884

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：889 / 892

页数：4

共 14 条

[1] *AC MED SCI, 2003, STRENGTH CLIN RE OCT
[2] [Anonymous], 1988, LANCET, V2, P349
[3] [Anonymous], 1986, LANCET, V2, P57
[4] [Anonymous], 2003, LANCET, V361, P2167
[5] Toward protecting the safety of participants in clinical trials
Califf, RM
Morse, MA
Wittes, J
Goodman, SN
Nelson, DK
DeMets, DL
Iafrate, RP
Sugarman, J
[J]. CONTROLLED CLINICAL TRIALS, 2003, 24 (03): : 256 - 271
[6] COLLINS R, 1995, LANCET, V345, P669
[7] Physician remuneration in industry-sponsored clinical trials: the case for standardized clinical trial budgets
Ferris, LE
Naylor, CD
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (08) : 883 - 886
[8] A change in scientific approach: from alternation to randomised allocation in clinical trials in the 1940s
Hart, PD
[J]. BRITISH MEDICAL JOURNAL, 1999, 319 (7209) : 572 - 573
[9] HUNT D, 1992, LANCET, V339, P753
[10] Squeezing academic research into a commercial straitjacket
Mayor, S
[J]. BRITISH MEDICAL JOURNAL, 2004, 328 (7447): : 1036 - 1036